Need help finding what you are looking for?
Contact Us
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2044650
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2044650
Botulinum Toxin Market Insights, Competitive Landscape, and Market Forecast - 2033
PUBLISHED:
PAGES: 187 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
The global Botulinum Toxin Market is valued at US$ 9.2 Bn in 2026 and is projected to reach US$ 17.7 Bn by 2033, growing at a CAGR of 9.80% during the forecast period. Botulinum toxin continues to gain strong clinical and commercial relevance as both therapeutic and aesthetic demand rises across global healthcare systems. Increasing preference for minimally invasive procedures, expanding neurological treatment applications, and rising cosmetic awareness are key factors supporting market expansion. Continuous improvements in neurotoxin formulations, along with wider accessibility of aesthetic treatments, are accelerating adoption across hospitals, dermatology clinics, and medspas worldwide. Growing investments in clinical research and product innovation are also strengthening long-term market growth prospects.
Market Insights
The market is experiencing strong growth momentum driven by expanding use across therapeutic and aesthetic indications. In therapeutic applications, botulinum toxin is widely used for chronic migraine, cervical dystonia, spasticity, and overactive bladder. In aesthetics, it is extensively applied for glabellar lines, forehead lines, and crow's feet reduction. Rising patient awareness, increasing disposable income, and the rapid expansion of cosmetic treatment centers are further fueling demand. Technological advancements in neurotoxin delivery and improved safety profiles are enhancing patient outcomes and procedure efficiency across global healthcare systems.
Drivers
Key drivers include rising prevalence of neurological disorders, increasing aging population, and growing demand for cosmetic enhancement procedures. The shift toward non-surgical aesthetic treatments is significantly boosting product adoption. Expanding therapeutic usage in migraine, spasticity, and bladder disorders continues to support steady demand. Continuous innovation by pharmaceutical companies and growing healthcare expenditure are further strengthening market growth. Increasing awareness among patients and clinicians is also contributing to wider acceptance across both developed and emerging economies.
Business Opportunity
The Botulinum Toxin Market offers significant opportunities through expansion into emerging economies and development of advanced neurotoxin formulations. Rising investment in R&D is enabling the creation of longer-lasting and more targeted therapies. Growing demand for aesthetic procedures in developing regions is opening new revenue channels for manufacturers. Strategic collaborations, geographic expansion, and product innovation are key growth strategies adopted by market players. Improving healthcare infrastructure and rising affordability are further expected to expand patient access globally.
Region Analysis
North America dominates the market due to advanced healthcare infrastructure, high adoption of aesthetic procedures, and strong presence of leading pharmaceutical companies. Europe shows steady growth supported by regulatory approvals and increasing cosmetic awareness. Asia Pacific is expected to register the fastest growth due to rising disposable incomes, expanding medical tourism, and growing aesthetic consciousness. Latin America and Middle East & Africa are emerging markets benefiting from improving healthcare access and increasing medical investments.
Key Players
The market is highly competitive with major players focusing on innovation and global expansion. Key companies include:
- AbbVie Inc. / Allergan Aesthetics
- Ipsen Pharma
- Merz Pharma GmbH & Co. KGaA
- Medytox Inc.
- Hugel, Inc.
- Revance Therapeutics, Inc.
- Evolus, Inc.
- Galderma S.A.
- Daewoong Pharmaceutical Co., Ltd.
- Lanzhou Institute of Biological Products Co., Ltd.
- US WorldMeds, LLC
- Supernus Pharmaceuticals, Inc.
- Metabiologics, Inc.
- Eisai Co., Ltd.
- Teoxane Laboratories
These companies continue to strengthen their positions through product development and strategic partnerships.
Segmentation
By Product
- Type A Botox Dysport Xeomin Others
- Type B
By Application
- Therapeutic Chronic Migraine Overactive Bladder Cervical Dystonia Spasticity Others Aesthetic
- Glabellar Lines Crow's Feet Forehead Lines Others
By End Use
- Hospitals
- Dermatology Clinics
- MedSpas and Cosmetic Centers
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Contents
1. Executive Summary
- 1.1. Global Botulinum Toxin Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2026
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Five Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors
3. Global Botulinum Toxin Market Outlook, 2020 - 2033
- 3.1. Global Botulinum Toxin Market Outlook, by Product Type, Value (US$ Bn) & Volume (Units), 2020-2033
- 3.1.1. Type A
- 3.1.1.1. Botox
- 3.1.1.2. Dysport
- 3.1.1.3. Xeomin
- 3.1.1.4. Others
- 3.1.2. Type B
- 3.1.1. Type A
- 3.2. Global Botulinum Toxin Market Outlook, by Application - Therapeutic, Value (US$ Bn) & Volume (Units), 2020-2033
- 3.2.1. Chronic Migraine
- 3.2.2. Overactive Bladder
- 3.2.3. Cervical Dystonia
- 3.2.4. Spasticity
- 3.2.5. Others
- 3.3. Global Botulinum Toxin Market Outlook, by Application - Aesthetic, Value (US$ Bn) & Volume (Units), 2020-2033
- 3.3.1. Glabellar Lines
- 3.3.2. Crow's Feet
- 3.3.3. Forehead Lines
- 3.3.4. Others
- 3.4. Global Botulinum Toxin Market Outlook, by End-use, Value (US$ Bn) & Volume (Units), 2020-2033
- 3.4.1. Hospitals
- 3.4.2. Dermatology Clinics
- 3.4.3. MedSpas and Cosmetic Centers
- 3.5. Global Botulinum Toxin Market Outlook, by Region, Value (US$ Bn) & Volume (Units), 2020-2033
- 3.5.1. North America
- 3.5.2. Europe
- 3.5.3. Asia Pacific
- 3.5.4. Latin America
- 3.5.5. Middle East & Africa
4. North America Botulinum Toxin Market Outlook, 2020 - 2033
- 4.1. North America Botulinum Toxin Market Outlook, by Product Type, Value (US$ Bn) & Volume (Units), 2020-2033
- 4.1.1. Type A
- 4.1.1.1. Botox
- 4.1.1.2. Dysport
- 4.1.1.3. Xeomin
- 4.1.1.4. Others
- 4.1.2. Type B
- 4.1.1. Type A
- 4.2. North America Botulinum Toxin Market Outlook, by Application - Therapeutic, Value (US$ Bn) & Volume (Units), 2020-2033
- 4.2.1. Chronic Migraine
- 4.2.2. Overactive Bladder
- 4.2.3. Cervical Dystonia
- 4.2.4. Spasticity
- 4.2.5. Others
- 4.3. North America Botulinum Toxin Market Outlook, by Application - Aesthetic, Value (US$ Bn) & Volume (Units), 2020-2033
- 4.3.1. Glabellar Lines
- 4.3.2. Crow's Feet
- 4.3.3. Forehead Lines
- 4.3.4. Others
- 4.4. North America Botulinum Toxin Market Outlook, by End-use, Value (US$ Bn) & Volume (Units), 2020-2033
- 4.4.1. Hospitals
- 4.4.2. Dermatology Clinics
- 4.4.3. MedSpas and Cosmetic Centers
- 4.5. North America Botulinum Toxin Market Outlook, by Country, Value (US$ Bn) & Volume (Units), 2020-2033
- 4.5.1. U.S. Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 4.5.2. U.S. Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 4.5.3. U.S. Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 4.5.4. U.S. Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 4.5.5. Canada Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 4.5.6. Canada Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 4.5.7. Canada Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 4.5.8. Canada Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 4.6. BPS Analysis/Market Attractiveness Analysis
5. Europe Botulinum Toxin Market Outlook, 2020 - 2033
- 5.1. Europe Botulinum Toxin Market Outlook, by Product Type, Value (US$ Bn) & Volume (Units), 2020-2033
- 5.1.1. Type A
- 5.1.1.1. Botox
- 5.1.1.2. Dysport
- 5.1.1.3. Xeomin
- 5.1.1.4. Others
- 5.1.2. Type B
- 5.1.1. Type A
- 5.2. Europe Botulinum Toxin Market Outlook, by Application - Therapeutic, Value (US$ Bn) & Volume (Units), 2020-2033
- 5.2.1. Chronic Migraine
- 5.2.2. Overactive Bladder
- 5.2.3. Cervical Dystonia
- 5.2.4. Spasticity
- 5.2.5. Others
- 5.3. Europe Botulinum Toxin Market Outlook, by Application - Aesthetic, Value (US$ Bn) & Volume (Units), 2020-2033
- 5.3.1. Glabellar Lines
- 5.3.2. Crow's Feet
- 5.3.3. Forehead Lines
- 5.3.4. Others
- 5.4. Europe Botulinum Toxin Market Outlook, by End-use, Value (US$ Bn) & Volume (Units), 2020-2033
- 5.4.1. Hospitals
- 5.4.2. Dermatology Clinics
- 5.4.3. MedSpas and Cosmetic Centers
- 5.5. Europe Botulinum Toxin Market Outlook, by Country, Value (US$ Bn) & Volume (Units), 2020-2033
- 5.5.1. Germany Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 5.5.2. Germany Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 5.5.3. Germany Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 5.5.4. Germany Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 5.5.5. Italy Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 5.5.6. Italy Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 5.5.7. Italy Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 5.5.8. Italy Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 5.5.9. France Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 5.5.10. France Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 5.5.11. France Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 5.5.12. France Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 5.5.13. U.K. Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 5.5.14. U.K. Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 5.5.15. U.K. Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 5.5.16. U.K. Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 5.5.17. Spain Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 5.5.18. Spain Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 5.5.19. Spain Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 5.5.20. Spain Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 5.5.21. Russia Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 5.5.22. Russia Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 5.5.23. Russia Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 5.5.24. Russia Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 5.5.25. Rest of Europe Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 5.5.26. Rest of Europe Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 5.5.27. Rest of Europe Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 5.5.28. Rest of Europe Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 5.6. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Botulinum Toxin Market Outlook, 2020 - 2033
- 6.1. Asia Pacific Botulinum Toxin Market Outlook, by Product Type, Value (US$ Bn) & Volume (Units), 2020-2033
- 6.1.1. Type A
- 6.1.1.1. Botox
- 6.1.1.2. Dysport
- 6.1.1.3. Xeomin
- 6.1.1.4. Others
- 6.1.2. Type B
- 6.1.1. Type A
- 6.2. Asia Pacific Botulinum Toxin Market Outlook, by Application - Therapeutic, Value (US$ Bn) & Volume (Units), 2020-2033
- 6.2.1. Chronic Migraine
- 6.2.2. Overactive Bladder
- 6.2.3. Cervical Dystonia
- 6.2.4. Spasticity
- 6.2.5. Others
- 6.3. Asia Pacific Botulinum Toxin Market Outlook, by Application - Aesthetic, Value (US$ Bn) & Volume (Units), 2020-2033
- 6.3.1. Glabellar Lines
- 6.3.2. Crow's Feet
- 6.3.3. Forehead Lines
- 6.3.4. Others
- 6.4. Asia Pacific Botulinum Toxin Market Outlook, by End-use, Value (US$ Bn) & Volume (Units), 2020-2033
- 6.4.1. Hospitals
- 6.4.2. Dermatology Clinics
- 6.4.3. MedSpas and Cosmetic Centers
- 6.5. Asia Pacific Botulinum Toxin Market Outlook, by Country, Value (US$ Bn) & Volume (Units), 2020-2033
- 6.5.1. China Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 6.5.2. China Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 6.5.3. China Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 6.5.4. China Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 6.5.5. Japan Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 6.5.6. Japan Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 6.5.7. Japan Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 6.5.8. Japan Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 6.5.9. South Korea Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 6.5.10. South Korea Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 6.5.11. South Korea Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 6.5.12. South Korea Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 6.5.13. India Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 6.5.14. India Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 6.5.15. India Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 6.5.16. India Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 6.5.17. Southeast Asia Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 6.5.18. Southeast Asia Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 6.5.19. Southeast Asia Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 6.5.20. Southeast Asia Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 6.5.21. Rest of SAO Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 6.5.22. Rest of SAO Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 6.5.23. Rest of SAO Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 6.5.24. Rest of SAO Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 6.6. BPS Analysis/Market Attractiveness Analysis
7. Latin America Botulinum Toxin Market Outlook, 2020 - 2033
- 7.1. Latin America Botulinum Toxin Market Outlook, by Product Type, Value (US$ Bn) & Volume (Units), 2020-2033
- 7.1.1. Type A
- 7.1.1.1. Botox
- 7.1.1.2. Dysport
- 7.1.1.3. Xeomin
- 7.1.1.4. Others
- 7.1.2. Type B
- 7.1.1. Type A
- 7.2. Latin America Botulinum Toxin Market Outlook, by Application - Therapeutic, Value (US$ Bn) & Volume (Units), 2020-2033
- 7.2.1. Chronic Migraine
- 7.2.2. Overactive Bladder
- 7.2.3. Cervical Dystonia
- 7.2.4. Spasticity
- 7.2.5. Others
- 7.3. Latin America Botulinum Toxin Market Outlook, by Application - Aesthetic, Value (US$ Bn) & Volume (Units), 2020-2033
- 7.3.1. Glabellar Lines
- 7.3.2. Crow's Feet
- 7.3.3. Forehead Lines
- 7.3.4. Others
- 7.4. Latin America Botulinum Toxin Market Outlook, by End-use, Value (US$ Bn) & Volume (Units), 2020-2033
- 7.4.1. Hospitals
- 7.4.2. Dermatology Clinics
- 7.4.3. MedSpas and Cosmetic Centers
- 7.5. Latin America Botulinum Toxin Market Outlook, by Country, Value (US$ Bn) & Volume (Units), 2020-2033
- 7.5.1. Brazil Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 7.5.2. Brazil Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 7.5.3. Brazil Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 7.5.4. Brazil Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 7.5.5. Mexico Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 7.5.6. Mexico Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 7.5.7. Mexico Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 7.5.8. Mexico Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 7.5.9. Argentina Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 7.5.10. Argentina Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 7.5.11. Argentina Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 7.5.12. Argentina Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 7.5.13. Rest of LATAM Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 7.5.14. Rest of LATAM Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 7.5.15. Rest of LATAM Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 7.5.16. Rest of LATAM Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 7.6. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Botulinum Toxin Market Outlook, 2020 - 2033
- 8.1. Middle East & Africa Botulinum Toxin Market Outlook, by Product Type, Value (US$ Bn) & Volume (Units), 2020-2033
- 8.1.1. Type A
- 8.1.1.1. Botox
- 8.1.1.2. Dysport
- 8.1.1.3. Xeomin
- 8.1.1.4. Others
- 8.1.2. Type B
- 8.1.1. Type A
- 8.2. Middle East & Africa Botulinum Toxin Market Outlook, by Application - Therapeutic, Value (US$ Bn) & Volume (Units), 2020-2033
- 8.2.1. Chronic Migraine
- 8.2.2. Overactive Bladder
- 8.2.3. Cervical Dystonia
- 8.2.4. Spasticity
- 8.2.5. Others
- 8.3. Middle East & Africa Botulinum Toxin Market Outlook, by Application - Aesthetic, Value (US$ Bn) & Volume (Units), 2020-2033
- 8.3.1. Glabellar Lines
- 8.3.2. Crow's Feet
- 8.3.3. Forehead Lines
- 8.3.4. Others
- 8.4. Middle East & Africa Botulinum Toxin Market Outlook, by End-use, Value (US$ Bn) & Volume (Units), 2020-2033
- 8.4.1. Hospitals
- 8.4.2. Dermatology Clinics
- 8.4.3. MedSpas and Cosmetic Centers
- 8.5. Middle East & Africa Botulinum Toxin Market Outlook, by Country, Value (US$ Bn) & Volume (Units), 2020-2033
- 8.5.1. GCC Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 8.5.2. GCC Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 8.5.3. GCC Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 8.5.4. GCC Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 8.5.5. South Africa Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 8.5.6. South Africa Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 8.5.7. South Africa Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 8.5.8. South Africa Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 8.5.9. Egypt Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 8.5.10. Egypt Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 8.5.11. Egypt Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 8.5.12. Egypt Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 8.5.13. Nigeria Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 8.5.14. Nigeria Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 8.5.15. Nigeria Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 8.5.16. Nigeria Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 8.5.17. Rest of Middle East Botulinum Toxin Market Outlook, by Product Type, 2020-2033
- 8.5.18. Rest of Middle East Botulinum Toxin Market Outlook, by Application - Therapeutic, 2020-2033
- 8.5.19. Rest of Middle East Botulinum Toxin Market Outlook, by Application - Aesthetic, 2020-2033
- 8.5.20. Rest of Middle East Botulinum Toxin Market Outlook, by End-use, 2020-2033
- 8.6. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2025
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. AbbVie Inc. / Allergan Aesthetics
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. Ipsen Pharma
- 9.4.3. Merz Pharma GmbH & Co. KGaA
- 9.4.4. Medytox Inc.
- 9.4.5. Hugel, Inc.
- 9.4.6. Revance Therapeutics, Inc.
- 9.4.7. Evolus, Inc.
- 9.4.8. Galderma S.A.
- 9.4.9. Daewoong Pharmaceutical Co., Ltd.
- 9.4.10. Lanzhou Institute of Biological Products Co., Ltd.
- 9.4.11. US WorldMeds, LLC
- 9.4.12. Supernus Pharmaceuticals, Inc.
- 9.4.13. Metabiologics, Inc.
- 9.4.14. Eisai Co., Ltd.
- 9.4.15. Teoxane Laboratories
- 9.4.1. AbbVie Inc. / Allergan Aesthetics
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.